Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer
✍ Scribed by G. Füst; B. Fekete; I. Angyal; Ágnes Jakab; A. Pál; Katalin Merétey; A. Falus; Katalin Török; Gy. Szegedi; Mária Kávai; Èva Puskás; Mária Csécsi-Nagy; T. Szabó; Ágota Lenkey; Mária Misz
- Book ID
- 118898429
- Publisher
- Elsevier Science
- Year
- 1981
- Tongue
- English
- Weight
- 971 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0022-1759
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Levels of circulating immune complex (clC) and complement split product C3d were studied in 86 patients with breast cancer (BC), 22 patients with benign breast disease (BD), and 72 age-and sex-matched blood-bank donors (NC), using solidphase Clq-protein A RIA, C I q-anti-lgG RIA, anti-C3d anti-lgG R
## Abstract Combination of multiple mRNA markers has been largely investigated for detection of circulating cancer cells. However, current PCR‐based methods are relatively expensive and time consuming. The aim of this study was to develop a membrane array‐based multimarker assay for detection of ci
The activation of C1 by circulating immune complexes in patients with rheumatoid arthritis was investigated. C1rC1s(C1-In)2 complexes in EDTA-plasma, reflecting C1 activation in vivo, were slightly raised in 35 of 57 patients with rheumatoid arthritis, though most patients had elevated levels of cir